Shahe Bagerdjian is an action-oriented healthcare executive with a well-established track record of organic and inorganic revenue growth, enterprise scaling, and cash flow optimization. He currently serves as President, CEO, and Board Member of International Isotopes Inc. (OTC:$INIS), a publicly traded manufacturer and distributor of radiopharmaceuticals, radioactive calibration sources, and medical device products specializing in applications for nuclear medicine, molecular imaging, and cancer therapy.Previously, he served as the Senior Vice President of Operations & Business Development at Global Medical Solutions (GMS) for more than ten years. During his tenure at GMS, he oversaw a team of over 400 employees across 11 countries, leading the company to become one of the largest vertically integrated radiopharmacy & radiopharmaceutical providers in the world, doubling in revenue and quintupling cash flow.Shahe got his start building computers for a radiopharmacy chain, then digitizing records for doctors at 16, and founded his first tech company at 18 years old. As a co-founder of multiple startups, Shahe has showcased his entrepreneurial expertise and innovative mindset across various sectors. His diverse background and extensive network uniquely position him to drive growth and encourage collaboration within the startup ecosystem.Shahe holds a B.S. in Business Law and a B.S. in Finance from California State University, Northridge, and he highly recommends you read High Output Management by Andy Grove, The Hard Thing About Hard Things by Ben Horowitz, and The Culture Series by Iain M. Banks.